Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | K132N |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 K132N lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). K132N results in elevation of ZMAT3 transcription, but fails to enhance CDKN1A or ATF3 expression compared to wild-type Tp53 in cultured cells (PMID: 31637714), and therefore, is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 K132N TP53 mutant TP53 inact mut TP53 K132N |
Transcript | NM_000546.6 |
gDNA | chr17:g.7675216C>G |
cDNA | c.396G>C |
Protein | p.K132N |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126112.2 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276698.3 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276697.1 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276698.1 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276699.1 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276697.3 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001276699.3 | chr17:g.7673747C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7675216C>G | c.396G>C | p.K132N | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|